<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[《中国临床新医学》杂志编辑部 -->Guideline and Consensus]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Expert consensus on pre-conception management of polycystic ovary syndrome with metabolic abnormalities(2026 edition)]]></title>
<link><![CDATA[https://www.zglcxyxzz.com/zglcxyyen/ch/reader/view_abstract.aspx?file_no=20260901&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>［Abstract］</b>　Polycystic ovary syndrome(PCOS) is commonly associated with metabolic abnormalities, which increases the risks of ovulation disorder, infertility, spontaneous abortion, pregnancy complications, and adverse offspring health outcomes. To improve pregnancy outcomes and offspring health in women with PCOS, pre-conception health management is of paramount importance. However, no standardized clinical guidelines currently exist for pre-conception management targeting this specific population. This consensus summarizes the epidemiology of metabolic abnormalities in PCOS, their impact on reproductive health, diagnostic criteria, and key aspects of pre-conception management. Based on clinical evidence and the experience of multidisciplinary experts, it proposes control targets for correcting metabolic abnormalities, introduces the pregnancy safety categories and usage recommendations for commonly used medications, and emphasizes that certain drugs are prescribed off-label, for which full disclosure and informed consent should be obtained from the patients before using these medications.]]></description>
<pubDate>2026/9/30 9:59:14</pubDate>
<category><![CDATA[Guideline and Consensus]]></category>
<author><![CDATA[Reproductive Medicine Branch, China International Exchange and Promotive Association for Medical and Health Care]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Reproductive Medicine Branch, China International Exchange and Promotive Association for Medical and Health Care</atom:name>
</atom:author>
<guid><![CDATA[https://www.zglcxyxzz.com/zglcxyyen/ch/reader/view_abstract.aspx?file_no=20260901&flag=1]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Chinese Expert Consensus on Implementation Strategies for Parenteral Nutrition in Critically Ill Patients(2026 Edition)]]></title>
<link><![CDATA[https://www.zglcxyxzz.com/zglcxyyen/ch/reader/view_abstract.aspx?file_no=20260801&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>［Abstract］</b>　Parenteral nutrition(PN) is a crucial component of nutritional support and is indicated for intensive care unit(ICU) patients whose energy and nutrient requirements cannot be met by enteral nutrition alone. To bridge the gap between rapidly evolving scientific evidence and clinical practice applications, the Formulation Committee of the Chinese Expert Consensus on Implementation Strategies for Parenteral Nutrition in Critically Ill Patients(2026 Edition), guided by evidence-based medicine and Delphi methodology, and comprehensively referring to the guidelines and consensus formulation process of the European Society for Clinical Nutrition and Metabolism(ESPEN), as well as the STAR(Scientific, Transparent, and Applicable Rankings) reporting standards of the guidelines, formulates this consensus. This consensus focuses on 5 core domains of parenteral nutrition in critically ill patients: indications and contraindications, treatment assessment, preparation standards, nutrient supplementation protocols, and storage specifications. A systematic process involving literature retrieval, quality appraisal, and evidence synthesis is conducted, followed by 2 rounds of Delphi expert consultation to achieve the final consensus. Accordingly, the Chinese Expert Consensus on Implementation Strategies for Parenteral Nutrition in Critically Ill Patients(2026 Edition) is formulated. The consensus aims to provide scientific guidance and practical reference for healthcare professionals to standardize the implementation of parenteral nutrition in clinical practice.]]></description>
<pubDate>2026/8/31 0:00:00</pubDate>
<category><![CDATA[Guideline and Consensus]]></category>
<author><![CDATA[Formulation Committee of the Chinese Expert Consensus on Implementation Strategies for Parenteral Nutrition in Critically Ill Patients(2026 Edition)]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Formulation Committee of the Chinese Expert Consensus on Implementation Strategies for Parenteral Nutrition in Critically Ill Patients(2026 Edition)</atom:name>
</atom:author>
<guid><![CDATA[https://www.zglcxyxzz.com/zglcxyyen/ch/reader/view_abstract.aspx?file_no=20260801&flag=1]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Evidence-based guideline for cardiac rehabilitation based on International Classification of Functioning, Disability and Health]]></title>
<link><![CDATA[https://www.zglcxyxzz.com/zglcxyyen/ch/reader/view_abstract.aspx?file_no=20260401&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>［Abstract］</b>　This guideline is established on the basis of the theoretical framework of International Classification of Functioning, Disability and Health(ICF) and in combination with the current best evidence-based medical evidence to systematically construct the protocols for assessment, intervention and management of cardiac rehabilitation. The content of this guideline covers key components including the application of ICF core sets in cardiac rehabilitation, the selection and criteria of functional assessment tools, risk stratification criteria, as well as individualized intervention and management, aiming to provide clinicians with standardized and systematic practical guidance and to improve the quality of cardiac rehabilitation services and the patients′ functional outcomes.]]></description>
<pubDate>2026/4/30 11:10:44</pubDate>
<category><![CDATA[Guideline and Consensus]]></category>
<author><![CDATA[Professional Committee for Rehabilitation Institution Management, Chinese Association of Rehabilitation Medicine, Professional Committee for Cardiovascular Disease Prevention and Rehabilitation, Chinese Association of Rehabilitation Medicine]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Professional Committee for Rehabilitation Institution Management, Chinese Association of Rehabilitation Medicine, Professional Committee for Cardiovascular Disease Prevention and Rehabilitation, Chinese Association of Rehabilitation Medicine</atom:name>
</atom:author>
<guid><![CDATA[https://www.zglcxyxzz.com/zglcxyyen/ch/reader/view_abstract.aspx?file_no=20260401&flag=1]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>